Charles Swofford MIT

Charley Swofford has been at the Center for Biomedical Innovation at MIT since 2022, where he is the Assistant Director for Biomanufacturing Initiatives. In this role, he manages collaborative sponsored research projects, including investigating ONT sequencing for adventitious agent detection and developing a continuous manufacturing testbed for virus-like particle (VLP) vaccine production. He also supports joint research projects among members of the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), a pre-competitive biopharmaceutical industry consortium focused on identifying and sharing best practices to mitigate the risk of adventitious agent contamination in biopharmaceutical manufacturing. Dr. Swofford received his Ph.D. in Chemical Engineering from the University of Massachusetts Amherst in 2014, where he engineered microbes for targeted cancer drug delivery.